We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Special report from the American Society of Hematology (ASH) Annual Meeting.
- Authors
Song, Kevin
- Abstract
Information about the topics discussed at the American Society of Hematology (ASH) annual meeting is presented. It highlights the results of the clinical trials regarding the availability of drugs indicated for multiple myeloma. It adds that pomalidomide and carfilzomib have continued to hold potentials for asymptomatic multiple myeloma (SMM) while the combination of bortezomib, melphalon and prednisone (VMP) have exemplified survival advantages.
- Subjects
AMERICAN Society of Hematology; ANNUAL meetings; CLINICAL trials; MULTIPLE myeloma treatment; PREDNISONE; MEDICAL research
- Publication
Oncology Exchange, 2012, Vol 11, Issue 1, p22
- ISSN
1705-2394
- Publication type
Proceeding